IL-12 (p35/p70) Antibody, anti-human, REAfinity™
Synonyms: IL12A, CLMF, IL-12A, NFSK, NKSF1, P35
RECOMBINANT
Bioz Star90/100 Bioz rating
1 Citation1 Image
Clone:
REA121 | B-T21
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for IL-12 (p35/p70) Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
Biotin
FITC
PE
PE-Vio 770
Vio B515
Recommended dilution:
1:10
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-103-741, 130-103-676
Description:
Human peripheral blood mononuclear cells (PBMCs) were either left unstimulated (left images) or stimulated with LPS/R848 for 6 hours. After 2 hours, brefeldin A was added. Cells were then stained with CD14 antibodies and fixed, permeabilized, and intracellularly stained with Anti-IL-12 (p35/p70) antibodies. Cells were then analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Intracellular flow cytometry applications
Vio B515
Description:
Human peripheral blood mononuclear cells (PBMCs) were either left unstimulated (left images) or stimulated with LPS/R848 for 6 hours. After 2 hours, brefeldin A was added. Cells were then stained with CD11c antibodies and fixed, permeabilized, and intracellularly stained with Anti-IL-12 (p35/p70) antibodies. Cells were then analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.
Specifications for IL-12 (p35/p70) Antibody, anti-human, REAfinity™
Overview

Interleukin-12 (IL-12) is a 70–75 kDa heterodimeric cytokine composed of a 40 kDa heavy chain and a 35 kDa light chain. It is produced mainly by monocytes and macrophages as well as dendritic cells, primarily in response to stimulation with bacterial or viral antigens. IL-12 has also been described to be produced by non-hematopoietic cells such as keratinocytes and epidermoid carcinomas. IL-12 displays various effects on both NK and T cells, playing an essential role in the interaction between innate and adaptive immunity: It induces the production of IFN-γ alone or in synergy with IL-2, is a co-stimulator of both NK and T cell proliferation, and enhances cytolytic activity of both cell types. Moreover, IL-12 promotes the development of T helper 1 (Tʜ1)-specific immune responses by promoting the differentiation of CD4+ cells towards a Tʜ1 phenotype while inhibiting the production of Tʜ2 cells. The antibody clone REA121 reacts with the p35 kDa chain and the p70 kDa heterodimer of human IL-12, but not with IL-12 p40. It recognizes the same epitope as clone B-T21.

Additional information: Clone REA121 displays negligible binding to Fc receptors.

Alternative names

IL12A, CLMF, IL-12A, NFSK, NKSF1, P35

Detailed product information

Technical specifications

Clone
REA121
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
IL-12 (p35/p70)
Molecular mass of antigen [kDa]
22
Distribution of antigen
macrophages, monocytes, dendritic cells
Entrez Gene ID
RRID
AB_2652326, AB_2652323, AB_2652322, AB_2652324, AB_2652329, AB_2652325, AB_2652330, AB_2652328, AB_2652327, AB_2652321

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for IL-12 (p35/p70) Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support